Epilepsy Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
Global Epilepsy Therapeutics Market is estimated to value over USD 15.2 billion by 2026 end and register a CAGR of over 3.2% during the forecast period 2019 to 2026.
The global epilepsy
therapeutics market size is inflating at a high growth rate due to an
ever-growing ageing population, increase in research and development activities
in developing as well as developed markets and adoption of anti-epileptics
owing to an increased number of epilepsy and seizure cases.
As per the WHO,
epilepsy affects more than 40 million people across the world. In epilepsy, the
brain starts to act abnormally, thus leading to frequent seizures that are
short spans of involuntary movements, which may involve the entire body or a
body part. These seizures sometimes result in causing unconsciousness and loss
of bowel control or bladder function. Treatment with surgery or medication can
curb these seizures in patients suffering from epilepsy.
Anti-epileptics are
provided to treat epilepsy by curbing down seizures, and these medications work
by decreasing the recurrent brain impulses that cause pain and seizures. High
occurrence of epilepsy, increase in the prevalence of injuries to the brain and
the increasing ageing population are crucial factors steering the epilepsy
therapeutics market growth. Moreover, increased efficacy of future therapeutics
related to epilepsy and growing acceptance and awareness of advanced
medications amongst the patient population are predicted to stimulate the
market in the upcoming years.
The hospital
pharmacies are predicted to subjugate the global market. Usually, for treatment
and diagnosis of neurology-based disorders, patients take advice from a
specialist and therefore, the hospital pharmacy is considered for
prescription-based medication. This can be credited to the major share
accounted by the segment in the market.
The North American Region is Predicted to Dominate the Global
Market
North America is
projected to dominate and account for a prominent global epilepsy therapeutics
market share. The North American region is prominently steered by a rising
patient pool, a high number of incidences related to neurological disorders,
injuries to the brain and increase in the number of epilepsy cases.
Furthermore, developing products of high efficacy, better outcomes and having
fewer side-effects shall possibly escalate the market growth in the region. The
Asia Pacific region is predicted to inflate with a noteworthy growth rate over
the forecast period. This is owing to the ever-increasing geriatric population
base, initiatives taken by the government in order to improve the healthcare
industry, increasing activities related to research and development and
increasing prevalence of epilepsy in the Asia Pacific region.
Key market players included in the global epilepsy
therapeutics industry are Pfizer Inc., UCB S.A, Bausch Health Companies Inc.,
Novartis AG, GlaxoSmithKline PLC, Teva Pharmaceutical Industries, Sunovion
Pharmaceuticals Inc., Eisai Co. Ltd., Upsher-Smith Laboratories LLC, Amneal
Pharmaceuticals LLC.
Request a Sample
Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3472&page=requestsample
Global Epilepsy Therapeutics Market Segmentation:
By
Product
- First Generation Epilepsy
Therapeutics
- Second Generation Epilepsy
Therapeutics
- Third Generation Epilepsy
Therapeutics
By
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase
a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3472&page=askfordiscount
FutureWise Key Takeaways:
- Growth prospects
- SWOT analysis
- Key trends
- Key data-points affecting market growth
Objectives
of the Study:
- To provide with an exhaustive analysis on the
global epilepsy therapeutics market by product, by distribution channel
and by region
- To cater comprehensive information on factors
impacting market growth (drivers, restraints, industry-specific restraints
and opportunities)
- To forecast and evaluate micro-markets and the
overall market
- To predict the market size, in key regions (along
with countries)— North America, Europe, Asia Pacific, Latin America and
Middle East & Africa
- To record, evaluate and analyse competitive
landscape mapping- technological advancements, product launches,
expansions and mergers
We
specialise in high-growth niche markets, assuring flexibility, agility and customised
solutions for our clients. Through in-depth market insights and consultancy, we
present our clients with the tools they need to be at the forefront of their
industry – a position secured for far more than the near future.
Contact Us:
Company
Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Comments
Post a Comment